VivoSight Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Later Stage VC
- Investors
-
11
VivoSight General Information
Description
Developer of an optical coherence tomography skin imaging system designed to visualize skin structure and vascular changes for clinical assessment and dermatological research. The company's system offers high-resolution three-dimensional imaging, deep tissue visualization, and fast non-invasive scanning, enabling dermatologists and academic skin researchers to accurately diagnose conditions and monitor skin health over time.
Contact Information
Website
www.vivosight.comCorporate Office
- Units 1&2 Maidstone Innovation Centre
- Gidds Pond Way
- Maidstone ME14 5FY
- England, United Kingdom
Corporate Office
- Units 1&2 Maidstone Innovation Centre
- Gidds Pond Way
- Maidstone ME14 5FY
- England, United Kingdom
VivoSight Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Later Stage VC | Completed | Generating Revenue | ||||
| 12. Later Stage VC | 25-Nov-2019 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 21-Dec-2017 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series C) | 01-Oct-2015 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series B) | 16-Feb-2015 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series A2) | 13-Jan-2014 | Completed | Generating Revenue | |||
| 7. Grant | 01-Jan-2014 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A1) | 15-Mar-2012 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 17-Feb-2011 | $3.69M | $7.5M | Completed | Generating Revenue | |
| 4. Early Stage VC | 08-Oct-2010 | $1.23M | $3.81M | Completed | Generating Revenue |
VivoSight Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A2 Ordinary | ||||||||
| A1 Ordinary | ||||||||
| A Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 7,799 | $0.001641 | $18.94 | $18.94 | 1x | $18.94 | 1.13% | |
| Ordinary | 15,000 | $0.001641 | $16.41 | $16.41 | 1x | $16.41 | 2.18% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
VivoSight Patents
VivoSight Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4138697-A1 | Treatment apparatus | Pending | 21-Apr-2020 | ||
| EP-4138697-A4 | Treatment apparatus | Pending | 21-Apr-2020 | ||
| GB-202005820-D0 | Treatment apparatus | Inactive | 21-Apr-2020 | ||
| US-12502217-B2 | Treatment apparatus | Active | 21-Apr-2020 | ||
| US-20230149081-A1 | Treatment apparatus | Inactive | 21-Apr-2020 | A61B18/203 |
VivoSight Signals
VivoSight Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Plutus One Capital | Venture Capital | Minority | ||
| NCL Technology Ventures | Venture Capital | Minority | ||
| Origin Capital (UK) | Venture Capital | Minority | ||
| Kent Pension Fund | Limited Partner | Minority | ||
| Smith & Nephew | Corporation | Minority |
VivoSight FAQs
-
When was VivoSight founded?
VivoSight was founded in 2006.
-
Where is VivoSight headquartered?
VivoSight is headquartered in Maidstone, United Kingdom.
-
What is the size of VivoSight?
VivoSight has 18 total employees.
-
What industry is VivoSight in?
VivoSight’s primary industry is Diagnostic Equipment.
-
Is VivoSight a private or public company?
VivoSight is a Private company.
-
What is VivoSight’s current revenue?
The current revenue for VivoSight is .
-
How much funding has VivoSight raised over time?
VivoSight has raised $20.8M.
-
Who are VivoSight’s investors?
Plutus One Capital, NCL Technology Ventures, Origin Capital (UK), Kent Pension Fund, and Smith & Nephew are 5 of 11 investors who have invested in VivoSight.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process